Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher A. Ludlam
Effects of Acute Angiotensin II Type 1 Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Parameters in Patients With Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP
Hypertension
Internal Medicine
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists in Rats With Heart Failure. Role of Kinins and Angiotensin II Type 2 Receptors.
Journal of Clinical Investigation
Medicine
Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers
European Journal of Preventive Cardiology
Epidemiology
Cardiovascular Medicine
Cardiology
Prognostic Value of Soluble Angiotensin II Receptor 1 and Soluble Angiotensin Converting Enzyme (CD 143) in Patients With Acute Leukemia
Acta Haematologica Polonica
Oncology
Hematology
Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure
Journal of Cardiovascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Acute Effects of Angiotensin-Converting Enzyme Inhibitor on the Failing Heart.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology